Dendritic cell therapy
This page covers all Dendritic cell therapy drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds.
Phase 1 pipeline (1)
- Autologous Tolerogenic Dendritic cells · Fundacion Clinic per a la Recerca Biomédica · Immunology
Induction of tolerogenic dendritic cells to suppress immune responses
Patent intelligence
- dendritic cell therapy patent landscape — aggregated cliff calendar, attackable patents, originator estates